May 26 coronavirus news

Cases of "black fungus" in India have risen to 10,000, the junior minister responsible for chemicals and fertilizers on Tuesday.

The disease, called mucormycosis, is a rare and potentially deadly infection that is increasingly being detected among recovered Covid patients in the country, especially those with diabetes. 

At least 120 deaths have been recorded in Maharashtra state, home to the most populous city Mumbai, according to CNN affiliate CNN-News 18. The state’s health minister Rajesh Tope said 2,245 cases of the disease have been recorded in Maharashtra alone. 

Meanwhile, several states faced a shortage of the drug Amphotericin B, which is used in the treatment of black fungus.

At least eight states, including Maharashtra, have declared black fungus a notifiable disease in accordance with state government directives to notify all cases.

Read more on black fungus:

RELATED

They recovered from Covid, only to die of 'black fungus.' Here's what we know

There were 4.1 million global Covid-19 cases reported in the week ending May 23 -- a 14% decrease from the previous week, the World Health Organization (WHO) reported Tuesday.

WHO also reported 84,000 new Covid-19 deaths worldwide, a 2% decrease from the prior week.

The largest decline in new cases and deaths was in the European region, the report noted. However, WHO warned global Covid cases remained high overall.

India reported the highest number of new cases by far -- 1,846,055 -- though that was a 23% decrease from the week prior.

In an update on virus variants of concern, WHO reported new evidence showing that community transmission from March to April in the UK was higher for the B.1.617 variant first identified in India than for the B.1.1.7 variant first identified in the UK.

The report also cites research showing the B.1.617 variant may cause Covid-19 vaccines to lose some capacity to neutralize the virus.

WHO emphasized the importance of virus control measures to manage the spread of variants.

Hawaii is dropping its statewide mask mandate for outdoor activities and relaxing a ban on "ocean sports" competitions, allowing popular surfing events to resume in the US state.

The state has consistently maintained some of the strictest Covid-19 rules in the US, including heavy restrictions on travel to the islands.

In a news conference Tuesday, Hawaii Gov. David Ige said the mask mandate will be dropped "effective immediately" and people will no longer be required to wear one while outside.

The mask mandate, however, will stay in effect for most indoor activities.

But Ige said changes to travel restrictions could also be on the cards.

The state also said Tuesday that a ban on ocean sports competitions will be lifted June 1. Additionally, state capital Honolulu is being given permission to restart other organized sports.

South Korea will lift some of its Covid-19 preventative measures for vaccinated people, including mandatory wearing of face masks outdoors, Prime Minister Kim Boo-kyum said on Wednesday. 

Those fully vaccinated will also be exempt from restrictions limiting the number of people who can use facilities such as restaurants, cafes, and wedding venues.

Starting June 1, people with at least one vaccine dose will not need to comply with the current ban on family gatherings of eight or more. 

South Korea’s Covid-19 preventative measures are expected to be adjusted at the end of September when more than 70% of the country’s population is expected to have had at least one vaccine dose.

More than 3.9 million people have received their first dose and more than 1.9 million people are fully vaccinated, according to a news release from the Korea Disease Control and Prevention Agency (KDCA).

South Korea reported 707 new Covid-19 cases from Tuesday, according to the KDCA. The country has recorded a total of 137,682 cases, including 1,940 deaths, since the pandemic began.

When Uddhab Gautam got his first vaccine dose back in February, Covid-19 cases in Nepal were low.

Now, three months later, coronavirus infections in the Himalayan nation have spiraled out of control, leading to a shortage of hospital beds and oxygen, and sending most of the country into lockdown.

But despite needing it more than ever, the 67-year-old retired banker has no idea when he'll get his second dose of Covishield, the AstraZeneca vaccine manufactured by the Serum Institute of India (SII).

Gautam's predicament is similar to one shared by millions worldwide: as India's own coronavirus crisis has spiraled, SII -- the world's largest vaccine maker -- can no longer export its goods.

Last week, the SII said it wouldn't restart deliveries to COVAX, a worldwide initiative aimed at distributing vaccines to countries regardless of wealth, until the end of this year.

While SII's decision will be a lifeline for India, which is still reporting about 200,000 new cases a day, the delay poses a huge problem for developing countries that depend on COVAX to control large outbreaks of their own.

The world is already 140 million doses short -- and by the end of June, that gap will have reached 190 million shots, the United Nations children's agency, one of the partners in COVAX, said last week. There is currently no timeframe for resolving the shortage, UNICEF said.

That creates a very real problem, not just for countries with limited access to vaccines where cases are exploding, but also for the whole world.

Read the full story:

RELATED

As India stalls on vaccine exports, world's most vulnerable fall deeper into Covid crisis